Foltz Katia Martins, Neto Aloysio Enck, Francisco Júlio César, Simeoni Rossana Baggio, Miggiolaro Anna Flávia Ribeiro Dos Santos, do Nascimento Thatyanne Gradowski, Mogharbel Bassam Felipe, de Carvalho Katherine Athayde Teixeira, Faria-Neto José Rocha, de Noronha Lúcia, Guarita-Souza Luiz César
Graduate Program in Health Sciences, School of Medicine, Pontifícia Universidade Católica do Paraná (PUCPR), Curitiba 80215-901, Paraná, Brazil.
Experimental Laboratory of Institute of Biological and Health Sciences, Pontifícia Universidade Católica do Paraná (PUCPR), Curitiba 80215-901, Paraná, Brazil.
Life (Basel). 2022 Jun 23;12(7):942. doi: 10.3390/life12070942.
Tracheal lesions are pathologies derived from the most diverse insults that can result in a fatal outcome. Despite the number of techniques designed for the treatment, a limiting factor is the extent of the extraction. Therefore, strategies with biomaterials can restructure tissues and maintain the organ's functionality, like decellularized Wharton's jelly (WJ) as a scaffold. The aim is to analyze the capacity of tracheal tissue regeneration after the implantation of decellularized WJ in rabbits submitted to a tracheal defect.
An in vivo experimental study was undertaken using twenty rabbits separated into two groups ( = 10). Group 1 submitted to a tracheal defect, group 2 tracheal defect, and implantation of decellularized WJ. The analyses were performed 30 days after surgery through immunohistochemistry.
Inner tracheal area diameter ( = 0.643) didn't show significance. Collagen type I, III, and Aggrecan highlighted no significant difference between the groups (both collagens with = 0.445 and the Aggrecan = 0.4).
The scaffold appears to fit as a heterologous implant and did not trigger reactions such as rejection or extrusion of the material into the recipient. However, these results suggested that although the WJ matrix presents several characteristics as a biomaterial for tissue regeneration, it did not display histopathological benefits in trachea tissue regeneration.
气管病变是由多种损伤引起的病理状况,可能导致致命后果。尽管设计了多种治疗技术,但一个限制因素是取材范围。因此,使用生物材料的策略可以重组组织并维持器官功能,比如将去细胞化的华通氏胶(WJ)作为支架。目的是分析在患有气管缺损的兔子中植入去细胞化WJ后气管组织再生的能力。
进行了一项体内实验研究,使用20只兔子,分为两组(每组n = 10)。第1组造成气管缺损,第2组造成气管缺损并植入去细胞化WJ。术后30天通过免疫组织化学进行分析。
气管内面积直径(p = 0.643)无显著差异。I型、III型胶原蛋白和聚集蛋白聚糖在两组之间无显著差异(两种胶原蛋白p = 0.445,聚集蛋白聚糖p = 0.4)。
该支架似乎适合作为异种移植物,且未引发诸如材料被受体排斥或挤出等反应。然而,这些结果表明,尽管WJ基质作为组织再生生物材料具有多种特性,但在气管组织再生中未显示出组织病理学益处。